Literature DB >> 16247442

p53 promotes adenoviral replication and increases late viral gene expression.

J A Royds1, M Hibma, B R Dix, L Hananeia, I A Russell, A Wiles, D Wynford-Thomas, A W Braithwaite.   

Abstract

The tumor suppressor protein, p53, plays a critical role in viro-oncology. However, the role of p53 in adenoviral replication is still poorly understood. In this paper, we have explored further the effect of p53 on adenoviral replicative lysis. Using well-characterized cells expressing a functional p53 (A549, K1neo, RKO) and isogenic derivatives that do not (K1scx, RKOp53.13), we show that virus replication, late virus protein expression and both wtAd5 and ONYX-015 virus-induced cell death are impaired in cells deficient in functional p53. Conversely, by transfecting p53 into these and other cells (IIICF/c, HeLa), we increase late virus protein expression and virus yield. We also show, using reporter assays in IIICF/c, HeLa and K1scx cells, that p53 can cooperate with E1a to enhance transcription from the major late promoter of the virus. Late viral protein production is enhanced by exogenous p53. Taken together, our data suggest that functional p53 can promote the adenovirus (Ad) lytic cycle. These results have implications for the use of Ad mutants that are defective in p53 degradation, such as ONYX-015, as agents for the treatment of cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16247442     DOI: 10.1038/sj.onc.1209185

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection.

Authors:  Natalie A Forrester; Garry G Sedgwick; Anoushka Thomas; Andrew N Blackford; Thomas Speiseder; Thomas Dobner; Philip J Byrd; Grant S Stewart; Andrew S Turnell; Roger J A Grand
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 2.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

3.  The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Authors:  M Kim; C T Williamson; J Prudhomme; D G Bebb; K Riabowol; P W K Lee; S P Lees-Miller; Y Mori; M M Rahman; G McFadden; R N Johnston
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

4.  Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression.

Authors:  Shih-Shin Chang; You-Chang Lo; Huey-Huey Chua; Hsin-Yi Chiu; Shu-Chun Tsai; Jen-Yang Chen; Kwok-Wai Lo; Ching-Hwa Tsai
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

5.  Potential role for p53 in the permissive life cycle of human cytomegalovirus.

Authors:  N C Casavant; M H Luo; K Rosenke; T Winegardner; A Zurawska; E A Fortunato
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models.

Authors:  Wenliang Dong; Jan-Willem H van Ginkel; Kam Y Au; Ramon Alemany; Janneke J M Meulenberg; Victor W van Beusechem
Journal:  Hum Gene Ther       Date:  2014-09-17       Impact factor: 5.695

7.  The p53 protein does not facilitate adenovirus type 5 replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.

Authors:  Maria Rovira-Rigau; Giulia Raimondi; Miguel Ángel Marín; Meritxell Gironella; Ramon Alemany; Cristina Fillat
Journal:  Mol Ther       Date:  2018-09-27       Impact factor: 11.454

9.  The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.

Authors:  Alexander V Kofman; Christopher Letson; Evan Dupart; Yongde Bao; William W Newcomb; David Schiff; Jay Brown; Roger Abounader
Journal:  Med Hypotheses       Date:  2013-05-02       Impact factor: 1.538

10.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.